ArticleClinical and translational radiation oncology2020

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer.

G W van Pelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.